FASIPLON
UNII XCA050IPGB

Substance Identification & Data

This profile provides standardized clinical and technical data for Fasiplon, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XCA050IPGB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 106100-65-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
XCA050IPGB
CAS Registry Number
106100-65-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
FASIPLON
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C13H15N5O2
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
MEBYKPLMXIRYRQ-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
INN ID
6410
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c12nc(c(c(n1cc(n2)-c3noc(n3)C)C)CC)OC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Fasiplon. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FASIPLON

Common Names & Synonyms

FASIPLON [INN]

Systematic Nomenclature

6-ETHYL-7-METHOXY-5-METHYL-2-(5-METHYL-1,2,4-OXADIAZOL-3-YL)IMIDAZO(1,2-A)PYRIMIDINE